These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5902055)

  • 1. Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.
    Arden GB; Kolb H
    Br Med J; 1966 Jan; 1(5482):270-3. PubMed ID: 5902055
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimalarial treatment of rheumatoid arthritis.
    Zvaifler NJ
    Med Clin North Am; 1968 May; 52(3):759-64. PubMed ID: 5653948
    [No Abstract]   [Full Text] [Related]  

  • 3. The EOG in rheumatoid arthritis.
    Pinckers A; Broekhuyse RM
    Acta Ophthalmol (Copenh); 1983 Oct; 61(5):831-7. PubMed ID: 6659891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ophthalmic side effects of chloroquine in patients with rheumatoid arthritis].
    Sarmela T; Kajander A
    Duodecim; 1968; 84(5):306-11. PubMed ID: 5670747
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimalarials in the treatment of rheumatoid arthritis.
    Zvaifler NJ
    Mod Treat; 1971 Nov; 8(4):769-77. PubMed ID: 4258497
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine treatment and the eye.
    Mäntyjärvi M
    Scand J Rheumatol; 1985; 14(2):171-4. PubMed ID: 4001889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
    Tzekov R
    Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarials as antirheumatic agents and the risk of ocular toxicity.
    Zvaifler NJ
    GP; 1966 Nov; 34(5):128-32. PubMed ID: 5917009
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI
    J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
    [No Abstract]   [Full Text] [Related]  

  • 12. Electro-oculogram findings in patients treated with antimalarial drugs.
    Kolb H
    Br J Ophthalmol; 1965 Nov; 49(11):573-90. PubMed ID: 5849422
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevention of drug-induced retinopathies.
    Crews SJ
    Trans Ophthalmol Soc U K (1962); 1966; 86():63-76. PubMed ID: 5335103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine].
    Cavagna L; Rossi P; Bogliolo L; Antoniazzi E; Gelmi C; Caporali R; Montecucco C
    Reumatismo; 2002; 54(3):226-31. PubMed ID: 12404030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.
    Costedoat-Chalumeau N; Dunogué B; Leroux G; Morel N; Jallouli M; Le Guern V; Piette JC; Brézin AP; Melles RB; Marmor MF
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):317-26. PubMed ID: 25672591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular changes caused by long-lasting use of chloroquine and its derivatives in rheumatoid disease].
    Drewnowska-Sochańska A; Kuprianowicz W; Petrus B
    Klin Oczna; 1970; 40(4):499-503. PubMed ID: 5453064
    [No Abstract]   [Full Text] [Related]  

  • 17. [The changes in the electric retinal activity during resochin treatment].
    Svĕrák J; Peregrin J; Salavec M
    Klin Monbl Augenheilkd; 1967 Nov; 151(5):633-40. PubMed ID: 5597424
    [No Abstract]   [Full Text] [Related]  

  • 18. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 20. On very short wavelength electroretinography. An original technique of diagnosis in infraclinical synthetic antimalarial retinopathies.
    Alfieri R; Sole P
    Ophthalmologica; 1969; 158 Suppl():661-8. PubMed ID: 5359763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.